SENESTECH
SenesTech is a biotech platform and research company that has developed an innovative technology for managing animal populations by fertility control. They develop non-lethal treatments that have the potential to be more effective, more humane, and less invasive to the environment than traditional management methods. SenesTech’s first product applies their revolutionary technology to a worldwide problem that has persisted since the Middle Ages: the proliferation of rats in both urban and agri... cultural settings. Their innovative compound is readily consumed by rats and leaves them non-reproductive with no other observable side effects. The rodents live out their normal 8-12 month life span without producing offspring. Since rapid reproduction is the root cause of rat infestation, this introduces a new paradigm to the science of pest control. When used as directed, their species-specific formulation is environmentally neutral, does not affect non-target animals, and has no impact on human health or fertility.
SENESTECH
Industry:
Biotechnology Health Care Medical
Founded:
2004-01-01
Address:
Flagstaff, Arizona, United States
Country:
United States
Website Url:
http://www.senestech.com
Total Employee:
11+
Status:
Active
Contact:
(928)779-4143
Email Addresses:
[email protected]
Total Funding:
14.47 M USD
Technology used in webpage:
SPF Domain Not Resolving Amazon IPv6 Person Schema Cloudflare Hosting Gravatar Profiles Cloudflare DNS Microsoft MediaElement.js
Similar Organizations
CEL-SCI
CEL-SCI is a biotechnology company developing immunotherapy products for the treatment of cancer and other infectious diseases.
Concert Pharmaceuticals
Concert Pharmaceuticals is a biotechnology company utilizing deuterium to develop novel medical candidates.
Exuma Biotech
EXUMA Biotech is a clinical-stage biotechnology company that focuses on discovering and developing CAR-T cell products for solid tumors.
Lineage Cell Therapeutics
Lineage Cell Therapeutics is a clinical-stage biotechnology company developing novel cellular therapies to treat unmet medical needs.
Knopp Biosciences
Knopp Neurosciences is a drug discovery and development company working on treatments for neurological disorders.
Novellus
Novellus is a biotechnology company working to develop engineered cellular medicines.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Current Employees Featured
Founder
Stock Details
Official Site Inspections
http://www.senestech.com Semrush global rank: 7.09 M Semrush visits lastest month: 596
- Host name: myshopify.com
- IP address: 23.227.38.65
- Location: Canada
- Latitude: 43.6319
- Longitude: -79.3716
- Timezone: America/Toronto
More informations about "SenesTech"
SenesTech - Crunchbase Company Profile & Funding
SenesTech is a biotech platform and research company that has developed an innovative technology for managing animal populations by fertility control. They develop non-lethal treatments that have the potential to be more effective, …See details»
SenesTech - Wikipedia
SenesTech, Inc. is an agricultural biotechnology life-sciences company, specializing in fertility management as a form of pest control. The company's primary product, ContraPest is designed to make brown and black rats infertile. SenesTech is headquartered in Phoenix, Arizona. See details»
SenesTech - Fertility Control for Managing Animal Pest Populations
SenesTech, Inc. represents that Evolveâ„¢ qualifies as a minimum risk pesticide under FIFRA Section 25(b) and is exempt from registration by the U.S. Environmental Protection Agency. …See details»
SenesTech (SNES) - Mission, Vision and Values
SenesTech, Inc. represents that Evolveâ„¢ qualifies as a minimum risk pesticide under FIFRA Section 25(b) and is exempt from registration by the U.S. Environmental Protection Agency. …See details»
SenesTech (SNES) - Company History
SenesTech's ContraPest isn't just a rat contraceptive. It is a game-changer in humane, effective pest management. Evolution Today the success of ContraPest can be seen across the United …See details»
Investors - SenesTech, Inc
Nov 12, 2024 SenesTech, Inc. represents that Evolveâ„¢ qualifies as a minimum risk pesticide under FIFRA Section 25(b) and is exempt from registration by the U.S. Environmental …See details»
SenesTech, Inc. (SNES) Company Profile & Facts - Yahoo Finance
See the company profile for SenesTech, Inc. (SNES) including business summary, industry/sector information, number of employees, business summary, corporate governance, key executives …See details»
SenesTech Company Profile - Office Locations, Competitors ... - Craft
Oct 29, 2024 SenesTech has 1 employees at their 1 location and $1.19 m in annual revenue in FY 2023. See insights on SenesTech including office locations, competitors, revenue, …See details»
SenesTech - Org Chart, Teams, Culture & Jobs - The Org
SenesTech, Inc. is a United States-based biotechnology platform and research company. The Company is engaged in developing a technology for managing animal populations by fertility …See details»
SenesTech - Overview, News & Similar companies | ZoomInfo.com
May 21, 2024 Founded in 2004, SenesTech is an Arizona based biotechnology company specializing in reproductive physiology for the purpose of humane animal popul ation …See details»
SenesTech - Contacts, Employees, Board Members, Advisors
SenesTech is an agricultural biotechnology life-sciences company for managing animal pest populations through fertility.See details»
SenesTech, Inc. (SNES) - Leadership
SenesTech, Inc. represents that Evolveâ„¢ qualifies as a minimum risk pesticide under FIFRA Section 25(b) and is exempt from registration by the U.S. Environmental Protection Agency. …See details»
SenesTech - Funding, Financials, Valuation & Investors - Crunchbase
SenesTech is an agricultural biotechnology life-sciences company for managing animal pest populations through fertility. Search Crunchbase. Start Free Trial . ... How much funding has …See details»
SenesTech Inc. (NASDAQ: SNES) Building Quickly Across Multiple …
Aug 23, 2024 SenesTech recently released Q2 2024 financial results and hosted a conference call, confirming 50% revenue growth in the just-ended quarter, and year-to-date growth 62% …See details»
SenesTech IncExecutive & Employee Information - GlobalData
The following section provides information on SenesTech Inc’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into …See details»
SenesTech Announces Third Quarter 2024 Financial Results
Nov 12, 2024 Record Revenue and Margin Performance. PHOENIX, Nov. 12, 2024 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), the …See details»
SenesTech Announces First Quarter 2024 Financial Results
May 9, 2024 SenesTech, Inc. represents that Evolveâ„¢ qualifies as a minimum risk pesticide under FIFRA Section 25(b) and is exempt from registration by the U.S. Environmental …See details»
Working At SenesTech: Company Overview and Culture - Zippia
Mar 14, 2024 The average a SenesTech salary in the United States is $55,340 per year. SenesTech employees in the top 10 percent can make over $91,000 per year, while …See details»
What is SenesTech? Company Culture, Mission, Values
See what employees say it's like to work at SenesTech. Salaries, reviews, and more - all posted by employees working at SenesTech.See details»